Platelet Monocyte Aggregates and Monocyte Chemoattractant Protein-1 are not Inhibited by Aspirin in Critical Limb Ischaemia

European Journal of Vascular and Endovascular Surgery

Volumn 33, Issue 6, 2007, Pages 725-730

  Cleanthis, M ^a,b   Bhattacharya, V ^a   Smout, J ^b   Ashour, H ^a   Stansby, G ^b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Aspirin; Monocyte chemoattractant protein 1; P selectin; Peripheral arterial disease; Platelet monocyte aggregates; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHEMOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRATE; PADGEM PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERMITTENT CLAUDICATION; ISCHEMIC HEART DISEASE; LEG ISCHEMIA; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

AGED; AGED, 80 AND OVER; ANGIOGRAPHY; ASPIRIN; BIOLOGICAL MARKERS; CHEMOKINE CCL2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; ISCHEMIA; LEG; MALE; MIDDLE AGED; P-SELECTIN; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 34247625955     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2006.12.025     Document Type: Article

References (36)

1. Harding S.A., Sommerfield A.J., Sarma J., Twomey P.J., Newby D.E., Frier B.M., et al. Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus. Atherosclerosis 176 (2004) 321-325
2. Harding S.A., Sarma J., Josephs D.H., Cruden M.D., Din J.D., Twomey P.J., et al. Upregulation of the CD40/CD40 ligand Dyad and platelet-monocyte aggregation in cigarette smokers. Circulation (2004) 1926-1929
3. Sener A., Ozsavei D., Oba R., Demirel G.Y., Uras F., and Yardimci K.T. Do platelet apoptosis, activation, aggregation, lipid peroxidation and platelet-leukocyte aggregate formation occur simultaneously in hyperlipidaemia?. Clin Biochem 38 (2005) 1081-1087
4. Ogura H., Kawasaki T., Tanaka H., Koh T., Tanaka R., Ozeki Y., et al. Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. Journal Trauma Inj Infect Crit Care 50 (2001) 801-809
5. Jensen M.K., de Nully Brown P., Lund B.V., Nielsen O.J., and Hasselbalch H.C. Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count. Eur J Haematol 66 (2001) 143-151
6. Kaplar M., Kappelmayer J.K., Kiss A., Szabo K., and Udvardy M. Increased leukocyte-platelet adhesion in chronic myeloproliferative disorders with high platelet counts. Platelets 11 (2000) 183-184
7. Powell C.C., Rohrer M.J., Barnard M.R., Peyton B.D., Furman M.I., and Michelson A.D. Chronic venous insufficiency is associated with increased platelet and monocyte activation and aggregation. J Vasc Surg 30 (1999) 844-851
8. Rohrer M.J., Claytor R.B., Garnette C.S., Powell C.C., Barnard M.R., Furman M.I., et al. Platelet-monocyte aggregates in patients with chronic venous insufficiency remain elevated following correction of reflux. Cardiovasc Surg 10 (2002) 464-469
9. Peyton B.D., Rohrer M.J., Furman M.I., Barnard M.R., Rodino L.J., Benoit S.E., et al. Patients with venous stasis ulceration have increased monocyte-platelet aggregation. J Vasc Surg 27 (1998) 1109-1116
10. Furman M.I., Benoit S.E., Barnard M.R., Valeri C.R., Borbone M.L., Becker R.C., et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 31 (1998) 352-358
11. Arefieva T.I., Provatorov S.I., Samko A.N., Krasnikova T.L., Resink T.J., Erne P., et al. Monocyte integrin expression and monocyte-platelet complex formation in humans with coronary restenosis. Clin Exp Pharmacol Physiol 28 (2001) 804-808
12. Sarma J., Laan C.A., Alam S., Jha A., Fox K.A.A., and Dransfield I. Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation 105 (2002) 2166-2171
13. Furman M.I., Barnard M.R., Krueger L.A., Fox M.L., Shilale E.A., Lessard D.M., et al. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 38 (2001) 1002-1006
14. Michelson A.D., Barnard M.R., Krueger L.A., Valeri C.R., and Furman M.I. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 104 (2001) 1533-1537
15. McCabe D.J.H., Harrison P., Mackie I.J., Sidhu P.S., Purdy G., Lawrie A.S., et al. Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. Br J Haematol (2004) 777-787
16. Egashira K. Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1. Hypertension 41 (2003) 834-841
17. Aiello R.J., Bourassa P.A., Lindsey S., Weng W., Natoli E., Rollins B.J., et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 19 (1999) 1518-1525
18. Dawson T.C., Kuziel W.A., Osahar T.A., and Maeda N. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 143 (1999) 205-211
19. Kumar A.G., Ballantyne C.M., Michael L.H., Kukielka G.L., Youker K.A., Lindsey M.L., et al. Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation 95 (1997) 693-700
20. Yamaguchi Y., Matsumura F., Takeya M., Ichiguchi O., Kuratsu J.I., Horiuchi T., et al. Monocyte chemoattractant protein-1 enhances expression of intercellular adhesion molecule-1 following ischemia-reperfusion of the liver in rats. Hepatology 27 (1998) 727-734
21. Egashira K., Zhao Q., Kataoka C., Ohtani K., Usui M., Charo I.F., et al. Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys. Circ Res 90 (2002) 1167-1172
22. Gawaz M., Neumann F.J., Dickfeld T., Koch W., Laugwitz K.L., Adelsberger H., et al. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation 98 (1998) 1164-1171
23. Massberg S., Vogt F., Dickfeld T., Brand K., Page S., and Gawaz M. Activated platelets trigger an inflammatory response and enhance migration of aortic smooth muscle cells. Thromb Res 110 (2003) 187-194
24. Matsui K., Ikeda U., Murakami Y., Yoshioka T., and Shimada K. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease. Am Heart J 145 (2003) 330-333
25. Smout J.D., Mikhailidis D.P., Shenton B.K., and Stansby G. Combination antiplatelet therapy in patients with peripheral vascular bypass grafts. Clin Appl Thromb Hemost 10 (2004) 9-18
26. Cleanthis M., Smout J., Bhattacharya V., Ashour H., Shenton B., and Stansby G. Treadmill exercise in claudicants on aspirin results in improved antioxidant status but only minimal platelet activation. Platelets 16 (2005) 446-452
27. Cassar K., Bachoo P., Ford I., Greaves M., and Brittenden J. Platelet activation is increased in peripheral arterial disease. J Vasc Surg 38 (2003) 99-103
28. Robless P.A., Okonko D., Lintott P., Mansfield A.O., Mikhailidis D.P., and Stansby G.P. Increased platelet aggregation and activation in peripheral arterial disease. Eur J Vasc Endovasc Surg 25 (2003) 16-22
29. Klinkhardt U., Bauersachs R., Adams J., Graff J., Lindhoff-Last E., and Harder S. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin Pharmacol Ther 73 (2003) 232-241
30. Serebruany V.L., Malinin A.I., Oshrine B.R., Sane D.C., Takserman A., Atar D., et al. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy. Thromb Res 113 (2004) 197-204
31. Petrkova J., Szotkowska J., Hermanova Z., Lukl J., and Petrek M. Monocyte chemoattractant protein-1 in patients with peripheral arterial disease. Mediators Inflamm 13 (2004) 39-43
32. Hoogeveen R.C., Morrison A., Boerwinkle E., Miles J.S., Rhodes C.E., Sharrett A.R., et al. Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: atherosclerosis risk in communities study. Atherosclerosis 183 (2005) 301-307
33. Kowalski J., Okopien B., Madej A., Zielinski M., Belowski D., Kalina Z., et al. Effects of atorvastatin, simvastatin, and fenofibrate therapy on monocyte chemoattractant protein-1 secretion in patients with hyperlipidemia. Eur J Clin Pharmacol 59 (2003 Jul) 189-193
34. Yang Y.Y., Hu C.J., Chang S.M., Tai T.Y., and Leu S.J. Aspirin inhibits monocyte chemoattractant protein-1 and interleukin-8 expression in TNF-alpha stimulated human umbilical vein endothelial cells. Atherosclerosis 174 (2004) 207-213
35. Cyrus T., Sung S., Zhao L., Funk C.D., Tang S., and Pratico D. Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation 106 (2002) 1282-1287
36. Deo R., Khera A., McGuire D.K., Murphy S.A., Meo Neto Jde P., Morrow D.A., et al. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 44 (2004) 1812-1818